Elixinol Wellness Annual Report 2021

Note 1: General information ................................................................................................................................................................................ 38 Note 2: Significant accounting policies .......................................................................................................................................................... 38 Note 3: Critical accounting judgements, estimates and assumptions ............................................................................................ 46 Note 4: Operating segments ................................................................................................................................................................................ 47 Note 5: Revenue ........................................................................................................................................................................................................ 50 Note 6: Other income.............................................................................................................................................................................................. 50 Note 7: Expenses........................................................................................................................................................................................................ 51 Note 8: Income tax.................................................................................................................................................................................................... 53 Note 9: Cash and cash equivalents................................................................................................................................................................... 54 Note 10: Trade and other receivables ................................................................................................................................................................ 54 Note 11. Inventories.................................................................................................................................................................................................... 55 Note 12: Prepayments, deposits and other..................................................................................................................................................... 56 Note 13: Investments accounted for using the equity method............................................................................................................. 56 Note 14: Property, plant and equipment........................................................................................................................................................... 57 Note 15: Right-of-use assets .................................................................................................................................................................................. 58 Note 16: Intangibles.................................................................................................................................................................................................... 60 Note 17: Trade and other payables........................................................................................................................................................................ 61 Note 18: Contract liabilities...................................................................................................................................................................................... 62 Note 19: Borrowings .................................................................................................................................................................................................... 62 Note 20: Lease liabilities ........................................................................................................................................................................................... 63 Note 21: Issued capital .............................................................................................................................................................................................. 63 Note 22: Reserves ........................................................................................................................................................................................................ 64 Note 23: Dividends...................................................................................................................................................................................................... 64 Note 24: Financial instruments ............................................................................................................................................................................. 64 Note 25: Fair value measurement ......................................................................................................................................................................... 67 Note 26: Remuneration of auditors..................................................................................................................................................................... 67 Note 27: Contingent liabilities ................................................................................................................................................................................ 67 Note 28: Commitments ............................................................................................................................................................................................ 68 Note 29: Key management personnel disclosures ...................................................................................................................................... 68 Note 30: Related party transactions ................................................................................................................................................................... 68 Note 31: Parent entity information...................................................................................................................................................................... 69 Note 32: Interests in subsidiaries............................................................................................................................................................................ 71 Note 33: Deed of cross guarantee ......................................................................................................................................................................... 71 Note 34: Cash flow information.............................................................................................................................................................................. 72 Note 35: Earnings per share..................................................................................................................................................................................... 73 Note 36: Share-based payments ........................................................................................................................................................................... 74 Note 37: Events after the reporting period ...................................................................................................................................................... 75 F INANCI AL REPORT 37 Company Overview Financial Report Shareholder Information Key Achievements and Milestones FY2021 Highlights Notes to the Consolidated Financial Statements for the year ended 31 December 2021